The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: LPS
The Acute Pancreatitis Panel panel contains 2 tests with 2 biomarkers.
Brief Description: The Acute Pancreatitis Panel is a diagnostic tool used primarily to assess and monitor patients suspected of having acute pancreatitis. This panel includes two essential tests: Amylase and Lipase, which measure the levels of these enzymes in the blood.
Collection Method: Blood Draw
Specimen Type: Serum
Test Preparation: No preparation required
The panel is often ordered when a patient presents with symptoms indicative of acute pancreatitis, such as severe abdominal pain, nausea, vomiting, and fever. It may also be ordered to monitor the progression of the disease or the effectiveness of treatment in patients with a known diagnosis of pancreatitis.
Amylase: This test measures the level of amylase in the blood, an enzyme produced primarily by the pancreas and the salivary glands. Amylase helps in the digestion of carbohydrates. Elevated levels in the blood can indicate acute pancreatitis or other pancreatic disorders.
Lipase: This test measures the concentration of lipase, an enzyme that plays a crucial role in the digestion of dietary fats. Lipase is produced by the pancreas, and its levels in the blood can significantly increase in cases of acute pancreatitis, often providing a more specific indication of the condition than amylase.
The Acute Pancreatitis Panel is primarily used to diagnose and manage:
Healthcare professionals use the results of the Acute Pancreatitis Panel to:
The Acute Pancreatitis Panel, comprising amylase and lipase tests, is a vital diagnostic tool for detecting and monitoring acute pancreatitis. Elevated levels of these enzymes in the blood can indicate pancreatic inflammation, guiding healthcare professionals in diagnosing, treating, and managing the condition effectively. Prompt and accurate testing is crucial for improving patient outcomes in acute pancreatic conditions.
We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.